ABO Blood Group and the Risk and Prognosis of Lymphoma

J Inflamm Res. 2023 Feb 22:16:769-778. doi: 10.2147/JIR.S401818. eCollection 2023.

Abstract

ABO blood group antigens exhibit alternative phenotypes and genetically derived structures that are located on the red cell surface. The role of ABO blood group in cancer biology has been intensely reported by several studies, and it is now widely recognized that ABO antigens are associated with the risk and prognosis of several types of tumors, namely gastric cancer and pancreatic cancer. However, there have been contentious limited issues with the association between the ABO blood group and lymphoma. In this narrative review, based on literature data, we discuss the role of ABO blood group in the risk and prognosis of lymphoma and summarize the current knowledge of the underlying pathogenic mechanisms of the association. The possible association of ABO blood group with racial disparities and pathological classification in lymphoma patients is also discussed.

Keywords: ABO blood group; disease susceptibility; lymphoma; race; survival.

Publication types

  • Review

Grants and funding

This work was supported by the Fundamental Research Funds for Henan University of Science and Technology (QNY13510001).